* Raises per-share price to 10 rand from 8.55 rand * Plans to delist Cipla Medpro when sale complete MUMBAI (Reuters) - Indian drugmaker Cipla Ltd on Thursday sweetened its offer by 17 percent to take over South Africa's third-largest drugmaker, Cipla Medpro South Africa Ltd, ending the uncertainty of an earlier offer that had been put on hold by the Indian company. Cipla, India's fifth-largest drugmaker by sales, said it would spend about $512 million, or 10 rand a share, to acquire Cipla Medpro and then delist the South African drugmaker. ...
Source: http://news.yahoo.com/kenyas-mumias-sugar-issues-profit-warning-150815793--finance.html
jk rowling qnexa kingdom of heaven national enquirer whitney houston arizona republican debate arizona debate enquirer
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.